Pedi MVI a) 5 mL
Reason Lack of Assurance of Sterility
14,801 recalls, newest first
Reason Lack of Assurance of Sterility
Reason Labeling: Not elsewhere classified. NDC number is incorrect on the container.
Reason Presence of Foreign Substance
Reason Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
Reason Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
Reason Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.
Reason Failed Impurities/Degradation Specifications: Out of specifications results for impurities.
Reason Presence of Particulate Matter
Reason Failed Impurities/Degradation Specifications: Level of iron exceeds the limit set by the USP monograph for it (USP limit is NMT 0.5 ug/g (ppm)).
Reason Defective Delivery System; potential to have inaccurate dosage delivery
Reason Defective Delivery System; potential to have inaccurate dosage delivery
Reason Labeling: Not Elsewhere Classified; Incorrect/Undeclared Excipients: Outdated previous version of label applied to products that incorrectly states one inactive ingredient.
Reason Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Reason Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Reason Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Reason Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.
Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.
Reason Presence of Foreign Tablets/Capsules: one foreign capsule identified as omeprazole 10 mg was found in the bottle
Reason Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.